Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor (vol 38, e70194, 2024)

被引：0
|
作者：
Hayashi, S. Y.
Pak, S.
Torlentino, A.
Rizzo, R. C.
Miller, M. T.
机构：
来源：
FASEB JOURNAL | 2025年 / 39卷 / 07期
关键词：
D O I：
10.1096/fj.202500971
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Somatic Mutations in Epidermal Growth Factor Receptor Signaling Pathway Genes in Non-small Cell Lung Cancers (vol 5, pg 1734, 2010)
    Lee, S. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : 1147 - 1147
  • [42] Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer
    Wu, Jenn-Yu
    Shih, Jin-Yuan
    ONCOTARGETS AND THERAPY, 2016, 9 : 6137 - 6145
  • [43] RETRACTION: A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells (Retraction of Vol 6, art no E19605, 2011)
    Jaganathan, S.
    Yue, P.
    Paladino, D. C.
    Bogdanovic, J.
    Huo, Q.
    Turkson, J.
    PLOS ONE, 2019, 14 (02):
  • [44] Dual epidermal growth factor receptor (EGFR) inhibition: Phase I study combining cetuximab (C225) and erlotinib (E) in advanced solid tumors
    Sangha, R.
    Ho, C.
    Beckett, L.
    Lau, D. H.
    Lara, P. N.
    Davies, A. M.
    Mack, P. C.
    Koslan, G. M.
    Holland, W. S.
    Gandara, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring (vol 67, pg 534, 2022)
    Nesvet, J. C.
    Antilla, K. A.
    Pancirer, D. S.
    Lozano, A. X.
    CLINICAL CHEMISTRY, 2023, 69 (03) : 308 - 308
  • [46] Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations
    Wang, Yuehong
    Singh, Ratnakar
    Wang, Liguang
    Nilsson, Monique
    Goonatilake, Ruchitha
    Tong, Pan
    Li, Lerong
    Giri, Uma
    Villalobos, Pamela
    Mino, Barbara
    Rodriguez-Canales, Jaime
    Wistuba, Ignacio
    Wang, Jing
    Heymach, John V.
    Johnson, Faye M.
    ONCOTARGET, 2016, 7 (30) : 47998 - 48010
  • [47] Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells (vol 105, pg 331, 2003)
    Klingler-Hoffmann, M.
    Bukczynska, P.
    Tiganis, T.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (06) : E7 - E8
  • [48] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Up-regulates Interleukin-6 in Cancer Cells and Induces Subsequent Development of Interstitial Pneumonia
    Ishiguro, Yukari
    Ishiguro, Hitoshi
    Miyamoto, Hiroshi
    ONCOTARGET, 2013, 4 (04) : 550 - 559
  • [49] Cell Density-Dependent Inhibition of Epidermal Growth Factor Receptor Signaling by p38α Mitogen-Activated Protein Kinase via Sprouty2 Downregulation
    Swat, Aneta
    Dolado, Ignacio
    Maria Rojas, Jose
    Nebreda, Angel R.
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (12) : 3332 - 3343
  • [50] Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1 (vol 6, pg 537, 1999)
    Kern, JA
    Akita, RW
    Sliwkowski, MX
    CANCER GENE THERAPY, 2000, 7 (02) : 166 - 166
12345